Fairmount Assists Xcelience and Powdersize in Striking Deal with Capsugel

Xcelience provides the company with specialized clinical trial manufacturing and supply capabilities for a broad range of solid dosage forms. Powdersize brings micronization capabilities that augment Capsugel’s formulation design services and premier bioavailability enhancement technology platform. MORRISTOWN, NJ, TAMPA, FL, and QUAKERTOWN, PA  – December 14, 2015 – Capsugel, Xcelience, and Powdersize recently announced the […]

Fairmount Partners Negotiates ICON’s Acquisition of PMG Research, Inc.

DUBLIN, Ireland – December 07, 2015 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PMG Research, Inc., an integrated network of clinical research sites operating from 12 metropolitan areas throughout the US. The acquisition will enhance […]